phencyclidine has been researched along with Migraine Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alt, A; Bleakman, D; Calligaro, DO; Clemens-Smith, A; Cohen, M; Dieckman, DK; Filla, SA; Gates, M; Ho, KH; Jarvie, K; Johnson, B; Johnson, KW; Katofiasc, M; Mattiuz, EL; Ogden, AM; Ornstein, PL; Phebus, LA; Rizkalla, G; Salhoff, C; Schenck, K; Schoepp, D; Stratford, RE; Weiss, B; Wright, RA | 1 |
1 other study(ies) available for phencyclidine and Migraine Disorders
| Article | Year |
|---|---|
Pharmacological characterization of the competitive GLUK5 receptor antagonist decahydroisoquinoline LY466195 in vitro and in vivo.
Topics: Animals; Benzodiazepines; Binding, Competitive; Blood Proteins; Calcium; Electrophysiology; Excitatory Amino Acid Antagonists; Humans; In Vitro Techniques; Isoquinolines; Ligands; Male; Migraine Disorders; Motor Activity; Muscle Contraction; Muscle, Smooth, Vascular; Neurons; Phencyclidine; Proto-Oncogene Proteins c-fos; Rabbits; Rats; Receptors, AMPA; Receptors, Kainic Acid; Saphenous Vein; Transfection | 2006 |